New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Breadcrumb
- Home
- Michael Seidman
Michael Seidman, MD

Professor
Specialties
- Hematology Oncology
Treatment Focus
- General Medical Oncology and Hematology
- Benign Hematology
Treatment Philosophy
I am excited to be joining the faculty of Fox Chase Cancer Center, after spending 16 years in community practice in the Philadelphia area. My interest in Medical Oncology began during medical school and residency when I had the opportunity to spend time at Fox Chase Cancer Center. I was taught by Medical Oncologists who were leaders in their fields, and understood the importance of clinical research to move our field forward. In addition, I was part of the medical team who cared for patients who were admitted to the hospital. These experiences served as the impetus to pursue a career as a Medical Oncologist/Hematologist and am thrilled to be coming back to “where I started”.
Growing up in the Philadelphia area, it has been important for me to provide top-notch care to members of our community.. I am eager to help expand the reach of Fox Chase Cancer Center, so that more patients can have access to care from a multidisciplinary. team as well as clinical trials close to their homes. My approach to patient care has always been listening to patients concerns and providing medical information in terms that patients can understand. I care for patients and their loved ones as if they were a member of my family.
Clinical Locations
-
Fox Chase Cancer Center - Buckingham2365 Heritage Center Drive
Furlong, PA 18925
Phone: 888-369-2427
-
Fox Chase Cancer Center - East Norriton2701 Dekalb Pike
East Norriton, PA 19401
Educational Background
- Temple University School of Medicine, MD, 2002
- Emory University, B.A. in Political Science, 1998
Certifications
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Medical Oncology
Honors & Awards
- Holy Redeemer Cancer Committee
- Jefferson Abington Hospital Cancer Committee
- Jefferson Abington Hospital Medical Executive Committee
- TOP DOCS for Oncology, Philadelphia Magazine 2020-2023
- New York University Medical Center, New York
- NY, Hematology/Oncology Chief Fellow, 2007-2008
- Oncology Fellow of the Year, 2006-2007
Selected Publications
Ali N, Malik F, Naglak M, Jafri S, Fidler C, Shahin M, Seidman M, and Cohen S. Bevacizumab-induced bleeding in colorectal and noncolorectal cancer patients in a community oncology setting: An Abington Memorial Hospital experience. Journal of Clinical Oncology 2017 35:15_suppl, e18250-e18250
Uprety D, Naglak M, Seidman M. Racial differences in survival of elderly patients with multiple myeloma in pre- and post-novel agent era. Journal of Geriatric Oncology 8 (2) March 2017, pp 125-127.
Seidman MJ et al. Pharmacokinetics of albumin-bound paclitaxel (ABX) in combination with temozolomide (TMZ) and oblimersen sodium (OBL) in patients with advanced melanoma. J Clin Oncol 26: 2008 (May 20 suppl; abstr 20030) Cheng J, Jann P, Seidman M, Valianou M, Lee H, Amatangelo M, Bachovchin W, Weiner L, and Cukierman E. Fibroblast activation protein overexpression confers an enhanced adherence and motility phenotype. AACR Meeting Abstract #5636, 2005.
Jason J, Montana E, Donald JF, Seidman M, Inge KL, and Campbell R. Kawasaki disease and the T-cell antigen receptor.
Human Immunology 59 (1998): 29-38.
The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.
Ratings Breakdown
Loading ...
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this
Patient comments